





























































































































































































































































































































































































































\(pH7.4\)at2S cc;B,i]FEat 2SÅé; C,DPPCvesicles \(O.98mh\(i\)at2S cÅé;D,
DPPC/DPPG(311)vesicles\(O.98 mM\)atSocÅé. (ma"emmuts-- )43; \(tumimmmdetaudiumwhm\)4,S;
\(\)4e(s-e-m•---nmM')46S• [Peptide] =20pM.6,
Table 1.ct-Helixcontentsofthe peptides undervariousconditions
Peptide ct-Helixcontent/9o
Buffer rrFE DPPC DPPCIDPPG(3/1)
2SOCSOOC2SOc 2sec sooc 2SOc sooc
4, 24IS 44 30 4S 55 S7
4,S s<s 48 <s <S 6S 69ag6 9497 82 91 93 n.d.a\) 97


































































Fig.4A,B.Profiles of theCF-leakageasafunction of the peptideconcentration.A,


















































O.g 1 io 1OO
log\([Peptide] /paM )
Fig.S.Profilesofthehemolysis asa functionof thepeptide concentration.\(O )4,;
\(e\)4,s;\(o\)4,;\(g\) 4,S.
Table2. Antmicrobiai activityofthe synthetic peptides
Minimuminhibitoryconcentration\(mg/mD
Organism ag3 4,S ag6 4,S GS
StaphylococcusaureusFDA209P 6.2S >1OO >1OO >1OO 3.13
S.aureusI840 6.2S >1OO >1OO >1OO 6.2S
Streptococcusepide7midisATCC12228 6.2S >1OO >1OO >1OO 3.13
EnterococcusfaecalisLS-IOI 6.2S >1OO >1OO >1OO 6.2S
BacillussubtilisPCI219 6.2S >1OO >1OO >1OO 6.2S
EscherichiacoliNIHfJC-2 >1OO >1OO >1OO >1OO >1OO
Shigellaflexnen'EW-1O >1OO >100 >1OO >1OO >1OO












































































































































































































































































































































Fig. 1. Structuresofthe amphiphilic ct-helicaloligopeptides. upper,aminoacid
sequencesofthedesignedpeptides. below s illustrationof ct-helicalwheelsofag6andag6S•
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indicatedaboveeachlane. B, DNaseIprotectionassay. TheplasmidDNAwas















































Fig.3. Circulardichroismspectraofthe peptides withorwithouttheplasmidDNA























































































































































































































Fig.7.Qptimum mixingofthepeptidesandthe plasmid DNA. Cellswereincubated
withpeptideZDNAcomplexcontainingO.66nmolto s. 3nmolof4,and1.3mgto10gegof
theplasmidDNAper 16mmdish.Afterincubation ' the efficiencywasanalyzedas































































































































































































































Inthisstudy,gusedfivekindsofcationicct-helical peptides consistingof18 residues
(Hel seriespeptides\)asnucleicacid-carriermolecules .The .prlmarystructures ofthe
peptidesandtheirhelicalwheelrepresentationareshown in Fig.1.E[elseries peptides
are composedofhydrophobicLeuandhydrophilicLys residues inratiosof13:S, 11:Z9:9,
7:11 ,andS:13\(abbreviatedasffelsfl3-S,flfi-7,9-9 ,andS-g3, respectively\).













































































































Fig.2. Agarosege1electrophoresis.A ,agarosegel shift assay. 'IheplasmidDNA
\(1OOng\)andseveralamounts ofthepeptides weremixed, followed by electrophoresison
anagarosegel(19owlv) stainedwithethidiumbromide .The charge ratio(peptide:DNA)
isindicated aboveeachlane. BDNase' ifprotection assay. The plasmidDNAwas
preineubatedwith thepeptides atthechargeratio indicated ahove each lane,followedby
treatment withDNaseIdescrib edin"Materialsandmethods". Mock-digestedsamplewas




























- if-x ff f! Npmop. -ff x 7A x mvumew""vtt :. -i :N q


















20S 220 24026020S220 240 260
Waveaength(nm) Wavelength(rm)
Fig.3. Circular dichroism spectraofthe peptides With or withouttheplasmid DNA.
Thepeptide wasdissolvedat 10geMinHBS. Measurementwasperformedin theabsence
(solid line\) orin thepresence \(brokenline\)of the plasmid DNAat2SeC.PanelA,B,C
























































Fig.4.Electron photomicrographs ofpeptide-DNA complexes.Peptide-DNA
complexeswerepreparedatachargeratio of2.0(peptide:DNA), andthemethodsusedfor
electronmicroscopyare describedin"Materialsandmethods". PanelsA-Eshowexamples
ofaggregationscomposed ofenegsg3-s, gfi-ew,9-9, ew-RgandS-g3,respectively,and
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Fig.1. ct-Helicalstructuresof43E ag,andwwe#fig-ew. Helicalgridrepresentationof43Eg

































































































































Fig. 3eCDspectra of 43EintheabsenceandpresenceofeggPCatalipid/peptideratioof
20/1 intheHBS (pH 7.4)(A),in20mMsodiumcitratebuffer(pHS.O) contaming1SOmiN\(ff

































i 10 1OO 1 goloo[Pepticte] /geM [Peptide]/paM
Fig.4.Perturbation activityofag3E atpH 7.4(squares) andpHS.O(circles). A,Calcein
leakageassays. Extentofleakege of calceinafter 2minasafunction ofpeptide
.concentrattonwas measured.B, Erythrocyte gysis assays.Extentof leakegefrom

















































































































































































PROCEDURES".Cross-hatchedbarsandopenbars indicate thecell viabilities in the
presenceof46-DNA-43Ecomplexand43Ealone,respectively.
93
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Fig.6.
ofthecomplexes
fiA-ew\(S.Omg,
amounts
3hlater,
hfrom
of4,E:
Effectof 43Eon
A,the
nmolof
2SOpe1
containing
of
e7
.ofwaell
transfectionefficiency
plasmidDNA
positivecharge\)were
offfBS.After
1091oFCS\(1
themedium,
Thenumbers
pm-ewandDNA.
(2.Sgeg,
10min,
mi\)was
andsubjected
ontheleftside
94
ofHeg
7.9
mixed
added.
Treatment
gary
nmol
'tooftheofthe
andthecytotoxic
ofnegative
f llowedby
themixturewasaddedto
Thecellswere
luciferaseassay
barsindicate
cellswith
i-.actlvines
charge\)andffest
additionofseveral
thecellsand'
incubatedfor48
asdescribedin
thechargeratio
chloroquinewas
\(legendofFig.6.continued\)
performedat100ptMduring thetransfectionprocedureintheabsenceofaj3E. The
numbersontherightsideof thebarsindicatetheluciferaseactivities\(RLU/mgproteinx
10'6\).B,cytotoxicitiesunder individuakransfectionconditionswereevaluatedby MTT
assayasdescribedin" Materialsandmethods".Cross-hatchedbarsandopen bars
indicatethecellviabilitiesin thepresenceofwaegrmremew-DNA-4,Ecomplexandag,Ealone,
respectively.
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